News | January 29, 2014

KLAS Report Evaluates Best-of-Breed, Enterprise Oncology Vendors

January 29, 2014 — KLAS spoke to 176 providers to identify strengths and weaknesses of best-of-breed and enterprise vendors and found the two competitive, according to the report Oncology 2013: Eyes Wide Open
 
Enterprise vendors such as Cerner and Epic were found to be making an impact in medical oncology, and providers report that best-of-breed vendors Elekta and Varian continue to deliver the necessary and desired functionality as well as the full oncology IT suite. McKesson was also recognized for its purchase of US Oncology and the iKnowMed solution. 
 
"The best-of-breed vendors have had to tighten up their interfacing capabilities to prove that they can compete with the enterprise vendors," said Monique Rasband, report author. "However, with only 67 percent of providers in the study attesting for meaningful use, it is clear that there is a lot of room for growth and support from all oncology vendors."
 
The vendors in this study include BMSi, Cerner, Elekta, Epic, IntrinsiQ, McKesson and Varian. 
 
For more information: www.klasresearch.com

Related Content

Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
MedLever Showcases Radiation Oncology Applications at ASTRO 2017
News | Radiation Therapy | October 05, 2017
MedLever demonstrated its flagship platform and applications that simplify clinical workflow, enable interoperability,...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Overlay Init